Trademark Overview
On Friday, August 29, 2025, a trademark application was filed for SALVAGENIX with the United States Patent and Trademark Office. The USPTO has given the SALVAGENIX trademark a serial number of 99365580. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 29, 2025. This trademark is owned by Salvagenix Inc.. The SALVAGENIX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity;; Veterinary preparations for digoxin, digitalis or other cardio-active glycoside toxicity; Pharmaceutical preparations for the treatment of pre-eclampsia;; Chemical reagents for medical or veterinary use; Pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia;; Chemical preparations for pharmaceutical or medical purposes, namely, for medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; Veterinary preparations for the treatment of pre-eclampsia;
